{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:57:26Z","timestamp":1789199846306,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The 3\u00a0most common inherited arrhythmia syndromes\u2014Brugada syndrome, congenital long QT syndrome and catecholaminergic polymorphic ventricular tachycardia\u2014were initially described in the previous century. Since then, research has evolved, which has enabled us to identify patients prior to the onset of potentially life-threatening symptoms. However, there are significant gaps in knowledge that complicate clinical management of these patients today. With this review paper, we aim to highlight the most important knowledge gaps in clinical research of these inherited arrhythmia syndromes.<\/jats:p>","DOI":"10.1007\/s12471-023-01797-w","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T07:02:20Z","timestamp":1688626940000},"page":"272-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Current gaps in knowledge in inherited arrhythmia syndromes"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-164X","authenticated-orcid":false,"given":"Puck J.","family":"Peltenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Roston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/adc.37.191.82","volume":"37","author":"MV Horan","year":"1962","unstructured":"Horan\u00a0MV, Venables\u00a0AW. Paroxysmal tachycardia with episodic unconsciousness. Arch Dis Child. 1962;37:82\u20135.","journal-title":"Arch Dis Child"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/hrt.37.8.830","volume":"37","author":"A Langslet","year":"1975","unstructured":"Langslet\u00a0A, Sorland\u00a0SJ. Surdocardiac syndrome of Jervell and Lange-Nielsen, with prolonged QT interval present at birth, and severe anaemia and syncopal attacks in childhood. Br Heart\u00a0J. 1975;37:830\u20132.","journal-title":"Br Heart J"},{"key":"1797_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada\u00a0P, Brugada\u00a0J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a\u00a0distinct clinical and electrocardiographic syndrome.\u00a0A multicenter report. J\u00a0Am Coll Cardiol. 1992;20:1391\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","volume":"106","author":"AA Wilde","year":"2002","unstructured":"Wilde\u00a0AA, Antzelevitch\u00a0C, Borggrefe\u00a0M, et\u00a0al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514\u20139.","journal-title":"Circulation"},{"key":"1797_CR5","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","volume":"10","author":"SG Priori","year":"2013","unstructured":"Priori\u00a0SG, Wilde\u00a0AA, Horie\u00a0M, et\u00a0al. HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932\u201363.","journal-title":"Heart Rhythm"},{"key":"1797_CR6","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstrom-Lundqvist\u00a0C, Mazzanti\u00a0A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: association for European paediatric and congenital cardiology (AEPC). Eur Heart\u00a0J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"},{"key":"1797_CR7","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.hrthm.2015.03.015","volume":"12","author":"C Hasdemir","year":"2015","unstructured":"Hasdemir\u00a0C, Payzin\u00a0S, Kocabas\u00a0U, et\u00a0al. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2015;12:1584\u201394.","journal-title":"Heart Rhythm"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.joa.2016.07.002","volume":"32","author":"C Antzelevitch","year":"2016","unstructured":"Antzelevitch\u00a0C, Yan\u00a0GX, Ackerman\u00a0MJ, et al. J\u2011wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. J\u00a0Arrhythm. 2016;32:315\u201339.","journal-title":"J Arrhythm"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J. 2022;43:3997\u20134126.","journal-title":"Eur Heart J"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jacep.2020.09.005","volume":"7","author":"S Viskin","year":"2021","unstructured":"Viskin\u00a0S, Hochstadt\u00a0A, Schwartz\u00a0AL, Rosso\u00a0R. Will I die from Brugada syndrome?: the rumination of risk stratification. JACC Clin Electrophysiol. 2021;7:223\u20135.","journal-title":"JACC Clin Electrophysiol"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.hrthm.2018.01.014","volume":"15","author":"A Milman","year":"2018","unstructured":"Milman\u00a0A, Andorin\u00a0A, Gourraud\u00a0JB, et\u00a0al. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: data from the survey on arrhythmic events in BRUgada syndrome (SABRUS). Heart Rhythm. 2018;15:716\u201324.","journal-title":"Heart Rhythm"},{"key":"1797_CR12","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehl205","volume":"27","author":"C Veltmann","year":"2006","unstructured":"Veltmann\u00a0C, Schimpf\u00a0R, Echternach\u00a0C, et al. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart\u00a0J. 2006;27:2544\u201352.","journal-title":"Eur Heart J"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","volume":"38","author":"J Sieira","year":"2017","unstructured":"Sieira\u00a0J, Conte\u00a0G, Ciconte\u00a0G, et\u00a0al. A score model to predict risk of events in patients with Brugada syndrome. Eur Heart\u00a0J. 2017;38:1756\u201363.","journal-title":"Eur Heart J"},{"key":"1797_CR14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/eurheartj\/ehaa763","volume":"42","author":"V Probst","year":"2021","unstructured":"Probst\u00a0V, Goronflot\u00a0T, Anys\u00a0S, et\u00a0al. Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome. Eur Heart\u00a0J. 2021;42:1687\u201395.","journal-title":"Eur Heart J"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jacep.2018.02.009","volume":"4","author":"S Kawada","year":"2018","unstructured":"Kawada\u00a0S, Morita\u00a0H, Antzelevitch\u00a0C, et\u00a0al. Shanghai score system for diagnosis of Brugada syndrome: validation of the score system and system and reclassification of the patients. JACC Clin Electrophysiol. 2018;4:724\u201330.","journal-title":"JACC Clin Electrophysiol"},{"key":"1797_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jacep.2020.08.032","volume":"7","author":"S Honarbakhsh","year":"2021","unstructured":"Honarbakhsh\u00a0S, Providencia\u00a0R, Garcia-Hernandez\u00a0J, et al. A primary prevention clinical risk score model for patients with Brugada syndrome (BRUGADA-RISK). JACC Clin Electrophysiol. 2021;7:210\u201322.","journal-title":"JACC Clin Electrophysiol"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1093\/eurheartj\/ehab254","volume":"42","author":"T Ishikawa","year":"2021","unstructured":"Ishikawa\u00a0T, Kimoto\u00a0H, Mishima\u00a0H, et\u00a0al. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. Eur Heart\u00a0J. 2021;42:2854\u201363.","journal-title":"Eur Heart J"},{"key":"1797_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/humu.9144","volume":"21","author":"E Schulze-Bahr","year":"2003","unstructured":"Schulze-Bahr\u00a0E, Eckardt\u00a0L, Breithardt\u00a0G, et al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat. 2003;21:651\u20132.","journal-title":"Hum Mutat"},{"key":"1797_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41588-021-01007-6","volume":"54","author":"J Barc","year":"2022","unstructured":"Barc\u00a0J, Tadros\u00a0R, Glinge\u00a0C, et al. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a\u00a0new mechanism of sodium channel regulation in disease susceptibility. Nat Genet. 2022;54:232\u20139.","journal-title":"Nat Genet"},{"key":"1797_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","volume":"123","author":"K Nademanee","year":"2011","unstructured":"Nademanee\u00a0K, Veerakul\u00a0G, Chandanamattha\u00a0P, et\u00a0al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270\u20139.","journal-title":"Circulation"},{"key":"1797_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02020-3","author":"Y Kotake","year":"2022","unstructured":"Kotake\u00a0Y, Barua\u00a0S, Kazi\u00a0S, et\u00a0al. Efficacy and safety of catheter ablation for Brugada syndrome: an updated systematic review. Clin Res Cardiol. 2022; https:\/\/doi.org\/10.1007\/s00392-022-02020-3.","journal-title":"Clin Res Cardiol"},{"key":"1797_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","volume":"14","author":"A Andorin","year":"2017","unstructured":"Andorin\u00a0A, Gourraud\u00a0JB, Mansourati\u00a0J, et\u00a0al. The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. Heart Rhythm. 2017;14:1147\u201354.","journal-title":"Heart Rhythm"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"e007143","DOI":"10.1161\/CIRCEP.118.007143","volume":"12","author":"A Mazzanti","year":"2019","unstructured":"Mazzanti\u00a0A, Tenuta\u00a0E, Marino\u00a0M, et\u00a0al. Efficacy and limitations of quinidine in patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2019;12:e7143.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1797_CR24","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","volume":"15","author":"TM Roston","year":"2018","unstructured":"Roston\u00a0TM, Jones\u00a0K, Hawkins\u00a0NM, et al. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review. Heart Rhythm. 2018;15:1791\u20139.","journal-title":"Heart Rhythm"},{"key":"1797_CR25","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","volume":"40","author":"C Van der Werf","year":"2019","unstructured":"Van der Werf\u00a0C, Lieve\u00a0KV, Bos\u00a0JM, et al. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. Eur Heart\u00a0J. 2019;40:2953\u201361.","journal-title":"Eur Heart J"},{"key":"1797_CR26","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","volume":"77","author":"SG Priori","year":"2021","unstructured":"Priori\u00a0SG, Mazzanti\u00a0A, Santiago\u00a0DJ, et\u00a0al. Precision medicine in catecholaminergic polymorphic ventricular tachycardia: JACC focus seminar 5\/5. J\u00a0Am Coll Cardiol. 2021;77:2592\u2013612.","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","volume":"8","author":"RW Sy","year":"2011","unstructured":"Sy\u00a0RW, Gollob\u00a0MH, Klein\u00a0GJ, et al. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2011;8:864\u201371.","journal-title":"Heart Rhythm"},{"key":"1797_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/europace\/euac177","volume":"25","author":"PJ Peltenburg","year":"2023","unstructured":"Peltenburg\u00a0PJ, Pultoo\u00a0SNJ, Tobert\u00a0KE, et al. Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia. Europace. 2023;25:619\u201326.","journal-title":"Europace"},{"key":"1797_CR29","doi-asserted-by":"publisher","first-page":"e002510","DOI":"10.1161\/CIRCGEN.119.002510","volume":"12","author":"JR Giudicessi","year":"2019","unstructured":"Giudicessi\u00a0JR, Lieve\u00a0KVV, Rohatgi\u00a0RK, et al. Assessment and validation of a\u00a0phenotype-enhanced variant classification framework to promote or demote RYR2 missense variants of uncertain significance. Circ Genom Precis Med. 2019;12:e2510.","journal-title":"Circ Genom Precis Med"},{"key":"1797_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jacep.2021.02.013","volume":"7","author":"TM Roston","year":"2021","unstructured":"Roston\u00a0TM, Kallas\u00a0D, Davies\u00a0B, et\u00a0al. Burst exercise testing can unmask arrhythmias in patients with incompletely penetrant catecholaminergic polymorphic ventricular tachycardia. JACC Clin Electrophysiol. 2021;7:437\u201341.","journal-title":"JACC Clin Electrophysiol"},{"key":"1797_CR31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","volume":"8","author":"TM Roston","year":"2015","unstructured":"Roston\u00a0TM, Vinocur\u00a0JM, Maginot\u00a0KR, et\u00a0al. Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol. 2015;8:633\u201342.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1797_CR32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","volume":"5","author":"C Van der Werf","year":"2012","unstructured":"Van der Werf\u00a0C, Nederend\u00a0I, Hofman\u00a0N, et al. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives. Circ Arrhythm Electrophysiol. 2012;5:748\u201356.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1797_CR33","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.hrthm.2015.03.033","volume":"12","author":"F Wanguemert","year":"2015","unstructured":"Wanguemert\u00a0F, Bosch Calero\u00a0C, Perez\u00a0C, et\u00a0al. Clinical and molecular characterization of a\u00a0cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2015;12:1636\u201343.","journal-title":"Heart Rhythm"},{"key":"1797_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","volume":"5","author":"PJ Schwartz","year":"2012","unstructured":"Schwartz\u00a0PJ, Crotti\u00a0L, Insolia\u00a0R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5:868\u201377.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1797_CR35","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","volume":"124","author":"PJ Schwartz","year":"2011","unstructured":"Schwartz\u00a0PJ, Crotti\u00a0L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124:2181\u20134.","journal-title":"Circulation"},{"key":"1797_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0735-1097(95)00426-2","volume":"27","author":"J Molnar","year":"1996","unstructured":"Molnar\u00a0J, Zhang\u00a0F, Weiss\u00a0J, Ehlert\u00a0FA, Rosenthal\u00a0JE. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. J\u00a0Am Coll Cardiol. 1996;27:76\u201383.","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-022-01716-5","author":"AT Bergeman","year":"2022","unstructured":"Bergeman\u00a0AT, Pultoo\u00a0SNJ, Winter\u00a0MM, et al. Accuracy of mobile 6\u2011lead electrocardiogram device for assessment of QT interval: a prospective validation study. Neth Heart\u00a0J. 2022; https:\/\/doi.org\/10.1007\/s12471-022-01716-5.","journal-title":"Neth Heart J"},{"key":"1797_CR38","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/CIRCULATIONAHA.120.050231","volume":"143","author":"JR Giudicessi","year":"2021","unstructured":"Giudicessi\u00a0JR, Schram\u00a0M, Bos\u00a0JM, et al. Artificial intelligence-enabled assessment of the heart rate corrected QT interval using a\u00a0mobile electrocardiogram device. Circulation. 2021;143:1274\u201386.","journal-title":"Circulation"},{"key":"1797_CR39","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","volume":"127","author":"L Crotti","year":"2013","unstructured":"Crotti\u00a0L, Johnson\u00a0CN, Graf\u00a0E, et\u00a0al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009\u201317.","journal-title":"Circulation"},{"key":"1797_CR40","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1161\/CIRCULATIONAHA.107.726950","volume":"11","author":"L Crotti","year":"2007","unstructured":"Crotti\u00a0L, Spazzolini\u00a0C, Schwartz\u00a0PJ, et al. The common long-QT syndrome mutation KCNQ1\/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a\u00a0mutation-specific risk stratification. Circulation. 2007;11:2366\u201375.","journal-title":"Circulation"},{"key":"1797_CR41","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/europace\/euad035","volume":"25","author":"L Crotti","year":"2023","unstructured":"Crotti\u00a0L. From gene-specific to function-specific risk stratification in long QT syndrome type 2: implications for clinical management. Europace. 2023;25:1320\u20132.","journal-title":"Europace"},{"key":"1797_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/europace\/euab238","volume":"24","author":"A Mazzanti","year":"2022","unstructured":"Mazzanti\u00a0A, Trancuccio\u00a0A, Kukavica\u00a0D, et al. Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-risk). Europace. 2022;24:614\u20139.","journal-title":"Europace"},{"key":"1797_CR43","first-page":"2219","volume":"118","author":"N Makita","year":"2008","unstructured":"Makita\u00a0N, Behr\u00a0E, Shimizu\u00a0W, et\u00a0al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J\u00a0Clin Invest. 2008;118:2219\u201329.","journal-title":"J Clin Invest"},{"key":"1797_CR44","first-page":"3925","volume":"39","author":"PJ Schwartz","year":"2018","unstructured":"Schwartz\u00a0PJ, Crotti\u00a0L, George\u00a0AL Jr.. Modifier genes for sudden cardiac death. Eur Heart\u00a0J. 2018;39:3925\u201331.","journal-title":"Eur Heart J"},{"key":"1797_CR45","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jacc.2009.05.029","volume":"54","author":"C Spazzolini","year":"2009","unstructured":"Spazzolini\u00a0C, Mullally\u00a0J, Moss\u00a0AJ, et\u00a0al. Clinical implications for patients with long QT syndrome who experience a\u00a0cardiac event during infancy. J\u00a0Am Coll Cardiol. 2009;54:832\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR46","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacep.2020.06.001","volume":"6","author":"JP Moore","year":"2020","unstructured":"Moore\u00a0JP, Gallotti\u00a0RG, Shannon\u00a0KM, et\u00a0al. Genotype predicts outcomes in fetuses and neonates with severe congenital long QT syndrome. JACC Clin Electrophysiol. 2020;6:1561\u201370.","journal-title":"JACC Clin Electrophysiol"},{"key":"1797_CR47","doi-asserted-by":"publisher","first-page":"e002419","DOI":"10.1161\/CIRCGEN.118.002419","volume":"12","author":"DJ Clemens","year":"2019","unstructured":"Clemens\u00a0DJ, Tester\u00a0DJ, Giudicessi\u00a0JR, et\u00a0al. International triadin knockout syndrome registry. Circ Genom Precis Med. 2019;12:e2419.","journal-title":"Circ Genom Precis Med"},{"key":"1797_CR48","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/CIRCULATIONAHA.105.592899","volume":"113","author":"PJ Schwartz","year":"2006","unstructured":"Schwartz\u00a0PJ, Spazzolini\u00a0C, Crotti\u00a0L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 2006;113:783\u201390.","journal-title":"Circulation"},{"key":"1797_CR49","doi-asserted-by":"publisher","first-page":"e007280","DOI":"10.1161\/CIRCEP.118.007280","volume":"12","author":"JM Bos","year":"2019","unstructured":"Bos\u00a0JM, Crotti\u00a0L, Rohatgi\u00a0RK, et al. Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome. Circ Arrhythm Electrophysiol. 2019;12:e7280.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1797_CR50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","volume":"67","author":"A Mazzanti","year":"2016","unstructured":"Mazzanti\u00a0A, Maragna\u00a0R, Faragli\u00a0A, et al. Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. J\u00a0Am Coll Cardiol. 2016;67:1053\u20138.","journal-title":"J Am Coll Cardiol"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-023-01797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-023-01797-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-023-01797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T13:16:51Z","timestamp":1691068611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-023-01797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":50,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s12471-023-01797-w","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"21 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.J.\u00a0Peltenburg, L.\u00a0Crotti, T.M.\u00a0Roston and C.\u00a0van der Werf declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}